CAS: 1391712-60-9 - CEP-37440
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | CEP-37440 REF: AN-AG009CAHCAS: 1391712-60-9 | 98+% | 103.00 €~1,059.00 € | Thu 09 May 24 |
 | CEP-37440 REF: TM-T2655CAS: 1391712-60-9 | 99.98% | 37.00 €~693.00 € | Thu 16 May 24 |
 | CEP-37440 REF: TR-C256690CAS: 1391712-60-9 | - - - | 13,280.00 € | Thu 20 Jun 24 |
 | CEP-37440 REF: 3D-RFC71260CAS: 1391712-60-9 | Min. 95% | To inquire | Thu 20 Jun 24 |
Ref: AN-AG009CAH
| 1mg | 103.00 € | |
| 2mg | 123.00 € | |
| 5mg | 145.00 € | |
| 10mg | 256.00 € | |
| 25mg | 497.00 € | |
| 50mg | 723.00 € | |
| 100mg | 1,059.00 € |
Estimated delivery in United States, on Thursday 9 May 2024
CEP-37440
CAS:1391712-60-9
CEP-37440 is an effective and specific Dual FAK/ALK inhibitor with IC50s of 120 nM(ALK cellular …
Formula:
C30H38ClN7O3
Purity:
99.98%
Color and Shape:
Solid
Molecular weight:
580.12
- Inhibitors
- Angiogenesis
- FAK
- Tyrosine Kinase/Adaptors
- See more categories
- ALK
- Cytoskeletal Signaling
Ref: TM-T2655
| 1mg | 37.00 € | |
| 2mg | 52.00 € | |
| 5mg | 78.00 € | |
| 10mg | 123.00 € | |
| 25mg | 251.00 € | |
| 50mg | 477.00 € | |
| 100mg | 693.00 € |
Estimated delivery in United States, on Thursday 16 May 2024
Ref: TR-C256690
| 100mg | 13,280.00 € |
Estimated delivery in United States, on Thursday 20 Jun 2024
CEP-37440
CAS:1391712-60-9
CEP-37440 is a molecule with potential anti-cancer properties. It has been investigated in vitro and …
Formula:
C30H38ClN7O3
Purity:
Min. 95%
Molecular weight:
580.12 g/mol
Ref: 3D-RFC71260
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire |
Estimated delivery in United States, on Thursday 20 Jun 2024
